Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide

Trade Name: 
Genvoya
Manufacturer/Distributor: 
Gilead Sciences
Classification: 
Antiretroviral agents
ATC Class: 
J05AR - antivirals for HIV infection, combination
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/11/26
Date Marketed in Canada (yyyy/mm/dd): 
2016/02/03
Presentation: 
Tablet: elvitegravir 150 mg + cobicistat 150 mg + emtrictabine 200mg + tenofovir alafenamide 10 mg. DIN: 02449498
Comments: 
A complete regimen for the treatment of HIV-1 in adults and pediatric patients 12 years of age and older (and weighing ≥ 35 kg) and with no known mutations associated with resistance to the individual components of Genvoya.